中国药物警戒 ›› 2012, Vol. 9 ›› Issue (5): 290-291.

• 管理及工作研究 • 上一篇    下一篇

1例社区获得性肺炎用药失误的思考

果茵茵1，赵慧1，2，*   

  1. 1 兰州大学第二医院药剂科，甘肃 兰州 730030；
    2 兰州大学药学院，甘肃 兰州 730000
  • 收稿日期:2011-12-12 出版日期:2012-05-10 发布日期:2015-08-10
  • 通讯作者: 赵慧,女,硕士,副主任药师,临床药学。E-mail:zhaohui1969ab@yahoo.com.cn
  • 作者简介:果茵茵，女，硕士，主管药师，临床药学。

The Thinking Originating from Medication Errors of One Case Suffering from Community-acquired Pneumonia

GUO Yin-yin1, ZHAO Hui1, 2, *   

  1. 1 The Pharmacy Department of Lanzhou University Second Hospital, Gansu Lanzhou 730030, China;
    2 The College of Pharmacy of Lanzhou University, Gansu Lanzhou 730000, China
  • Received:2011-12-12 Online:2012-05-10 Published:2015-08-10

PDF (PC)

233

摘要： 目的探讨社区获得性肺炎的初始治疗方案及药学监护。方法通过1例患者的用药失误对社区获得性肺炎的初始经验性治疗进行归纳和总结，总结药学监护点。结果该患者入院后未及时行支原体抗体检测，初始治疗给予头孢他啶联合利巴韦林，治疗后期更换为阿奇霉素联合头孢曲松及炎琥宁注射液，并在治疗过程中出现过敏反应。结论社区获得性肺炎的经验治疗应覆盖非典型病原体，临床药师应及时进行药学监护，防止不良反应的发生。

关键词: 社区获得性肺炎, 不良反应, 药学监护

Abstract: Objective To investigate the therapeutic methods and pharmaceutical care of community-acquired pneumonia. Methods Through analyzing medication errors, the primary therapeutic experiences of community-acquired pneumonia were summarized. Results The patient didn't immediately take the mycoplasma body test after hospitalization. At the beginning of treatment, the doctor selected Ceftazidime and Ribavirin. At the last stage of treatment, the drugs were changed to Azithromycin, Ceftriaxone and Potassium Sodium Dehydroandroan drographolide Succinate for Injection. During the period of hospitalization, the patient appeared anaphylaxis. Conclusion We should empirically cover untypical pathogen in treating CAP. The clinical pharmacists should timely do pharmaceutical care in order to avoid the adverse drug reaction.

Key words: community-acquired pneumonia, adverse reaction, pharmaceutical care